Clinical Trial Update: A Study of ASP1012 in Adults With Solid Tumors [Phase 1]

View source ↗

Summary

A Phase 1 study of ASP1012 in adults with solid tumors has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumor

Drugs mentioned

• ASP1012

Snippet

Sponsor: Astellas Pharma Global Development, Inc. | Conditions: Solid Tumor | Phase 1 | Status: TERMINATED